mounjaro patent expiration tirzepatide patent expiry Generic Zepbound: Landscape & Options In weight loss battle, Novo

Users who dislike large capsules

Overall Adverse Event Rates Dose Group Any Adverse Event (%) GI Adverse Events (%) Discontinuation Due to AE (%) Placebo 72.1% 32.6% 0% 1 mg 88.6% 48.6% 2.9% 4 mg (escalated) 88.6% 60.0% 5.7% 4 mg (single dose) 90.9% 63.6% 6.1% 8 mg (escalated) 87.5% 57.5% 5.0% 8 mg (single dose) 88.6% 62.9% 5.7% 12 mg (escalated) 97.2% 66.7% 8.3% Source: Jastreboff AM, Kaplan LM, Fras JP, et al

3 combining codes into themes

A purity test (HPLC) measures how much of the powder is the intended compound, an identity test confirms it's the right one, and it's screened for bacterial residue

The timing question here is about cessation rather than dosing

The B12 component remains the same regardless of indication